These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 1812495)

  • 1. Pharmaco-electroencephalography: a science ignored.
    Fink M
    Pharmacopsychiatry; 1991 Nov; 24(6):183-4. PubMed ID: 1812495
    [No Abstract]   [Full Text] [Related]  

  • 2. Predictive value of pharmaco-electroencephalography in early human-pharmacological evaluations of psychoactive drugs. First example: savoxepine.
    Herrmann WM; Schärer E; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):196-205. PubMed ID: 1687485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmaco-EEG profile of maroxepine: third example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
    Herrmann WM; Schärer E; Wendt G; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):214-24. PubMed ID: 1812498
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmaco-electroencephalography in Phase I.
    Luthringer R; Boeijinga PH
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():95. PubMed ID: 12809085
    [No Abstract]   [Full Text] [Related]  

  • 5. Animal pharmaco-EEG: models, facts and fallacies.
    Ruigt GS
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():59-61. PubMed ID: 12575469
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmaco-EEG profile of levoprotiline: second example to discuss the predictive value of pharmaco-electroencephalography in early human pharmacological evaluations of psychoactive drugs.
    Herrmann WM; Schärer E; Wendt G; Delini-Stula A
    Pharmacopsychiatry; 1991 Nov; 24(6):206-13. PubMed ID: 1812497
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmaco-electroencephalography and pharmacokinetic-pharmacodynamic modeling in drug development: focus on preclinical steps.
    Danhof M; Visser SA
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():127-8. PubMed ID: 12585231
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmaco-EEG in the first months of life.
    de Weerd AW
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():93. PubMed ID: 12809084
    [No Abstract]   [Full Text] [Related]  

  • 9. Uses of pharmaco-EEG and pharmacokinetic-pharmacodynamic modeling in the clinical scenario.
    Barbanoj MJ; Valle M; Kulisevsky J; Pérez V; Gambús P
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():139-44. PubMed ID: 12575481
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmaco-electroencephalography and pharmacokinetic/pharmacodynamic modeling in basic research: focus on human pharmacology.
    Valle M; Barbanoj MJ; Jané F
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():129-37. PubMed ID: 12575480
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complementary psychometric methods in pharmaco-electroencephalography research.
    Emegbo S; Hindmarch I
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl D():13. PubMed ID: 12809078
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmaco-EEG analysis by means of FFT and FAD.
    Szelenberger W; Skalski M; Franaszczuk P; Mitraszewski P; Blinowska K
    Acta Physiol Pol; 1989; 40(4):423-30. PubMed ID: 2485616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Predicting the effects of haloperidol on schizophrenics by quantitative pharmaco-EEG].
    Zhang XL
    Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1992 Oct; 25(5):300-2, 318. PubMed ID: 1291253
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Dextrose and vigilance: the effect of dextrose on the spectro-analytic parameters of pharmaco-EEG].
    Gessner B; Cnota PJ; Schaaf B
    EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb; 1992 Sep; 23(3):158-62. PubMed ID: 1425394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Classification and evaluation of the pharmacodynamics of psychotropic drugs by single-lead pharmaco-EEG, EEG mapping and tomography (LORETA).
    Saletu B; Anderer P; Saletu-Zyhlarz GM; Arnold O; Pascual-Marqui RD
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():97-120. PubMed ID: 12575493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evidence of a pharmacokinetic-pharmacodynamic relationship between pharmaco-EEG in healthy subjects after administration of cyclandelate].
    Dimpfel W; Schober F; Wedekind W; Kleinbloesem C; Coors C
    Arzneimittelforschung; 1994 Sep; 44(9):999-1004. PubMed ID: 7986255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical applications of pharmaco-EEG in psychiatry: the prediction of response to treatment with antipsychotics.
    Galderisi S
    Methods Find Exp Clin Pharmacol; 2002; 24 Suppl C():85-9. PubMed ID: 12575491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Prognostic value of pharmaco-EEG in depression treated with moclobemide].
    Wiśniewski G; Jakitowicz J; Nowicki Z; Pankiewicz P
    Psychiatr Pol; 2002; 36(6 Suppl):93-8. PubMed ID: 12647427
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmaco-EEG profiles of typical and atypical antidepressants.
    Saletu B
    Adv Biochem Psychopharmacol; 1982; 32():257-68. PubMed ID: 7090895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative pharmaco-electroencephalography in the discovery of a new group of psychotropic drugs.
    Itil TM
    Dis Nerv Syst; 1972 Aug; 33(8):557-9. PubMed ID: 4405375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.